CDI Laboratories, Inc. — Form D
CDI Laboratories, Inc. of MAYAGUEZ, PR, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-15. The offering totals $5.0M, of which $2.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-01-15
- Form: D
- Accession: 0001646316-21-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $2.1M
- Remaining: $2.9M
- Minimum investment: $25K
- Investors: 29
- Date of first sale: 2020-12-31
- Security types: equity
- Revenue range: $1,000,001 - $5,000,000
- SEC file number: 021-386496
Issuer
- Name: CDI Laboratories, Inc.
- CIK: 0001646316
- Entity type: Corporation
- Jurisdiction: PUERTO RICO
- Address: 12 W Mendez Vigo Avenue 2nd Floor, MAYAGUEZ, PR, 00682
- Phone: 787-806-4001
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Jef Jose Boeke | Director | New York, NY |
| Joseph Jose Bonaventura | Director | Beaufort, NC |
| Antoine Jose de Marsily | Director | San Juan, PR |
| Paul Jose Horan | Director | Kennett Square, PA |
| Ignacio Jose Pino Lopez-Castro | Director | Mayaguez, PR |
| Ignacio Jose Pino Lopez-Castro | Executive Officer | Mayaguez, PR |
| Paul Daniel Horan | Director | Kennett Square, PA |
| Jef Daniel Boeke | Director | New York, NY |
| Daniel Daniel Eichinger | Director | Mayaguez, PR |
| Joseph Daniel Bonaventura | Director | Beaufort, NC |
Other filings by this issuer (1)
More